Work

An Update of Recent Trials with Vildagliptin, a Dipeptidyl Peptidase-4 Inhibitor for the Treatment of Type 2 Diabetes

Year: 2009

Type: article

Source: Journal of Pharmacy Technology

DOI: 10.1177/875512250902500404

Authors: John T Johnson, Kish L Golden, Rogelio Braceras

Institutions: Presbyterian College, Wayne State University, Daiichi Sankyo (United States)

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1998118816

FWCI: 0.484

Cites: 22

Cited by: 3

Related to: 10